United States Biotechnology & Medical Research

Cascadian Therapeutics Inc (CASC)

Track

Ticker: CASC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
493.32
Quantity 90,433 -21.3%
Value US$787,834
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
244.64
Quantity 86,308 -33.1%
Value US$2,385,324
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
163.82
Quantity 52,874 -37.1%
Value US$4,597,688
Fyfe Gwen A.
Transaction date
Purchase
Price
4.12
Quantity 1,666 +100.0%
Value US$6,857
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
3.93
Quantity 1,000 +2.6%
Value US$3,927
LOVE TED W Non-Executive Director
Transaction date
Purchase
Price
4.24
Quantity 23,000 +546.4%
Value US$97,520
HENNEY CHRISTOPHER S Non-Executive Director
Transaction date
Purchase
Price
4.11
Quantity 25,324 +102.6%
Value US$103,973
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
3.76
Quantity 20,500 +114.4%
Value US$77,039
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
1.15
Quantity 45,000 +72.0%
Value US$51,746
Myers Scott Dunseth President and CEO Executive Director
Transaction date
Purchase
Price
0.80
Quantity 62,500 +inf%
Value US$50,000
HAUSMAN DIANA Chief Medical Officer Officer
Transaction date
Purchase
Price
4.65
Quantity 5,747 +inf%
Value US$26,724
SPIEGELMAN DANIEL K Non-Executive Director
Transaction date
Purchase
Price
1.59
Quantity 10,000 +32.6%
Value US$15,856
SPIEGELMAN DANIEL K Non-Executive Director
Transaction date
Purchase
Price
1.63
Quantity 10,000 +48.4%
Value US$16,271
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
1.73
Quantity 55,197 +1.7%
Value US$95,662
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
1.73
Quantity 98,298 +1.6%
Value US$170,360
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
1.88
Quantity 79,434 +2.5%
Value US$149,249
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
1.88
Quantity 145,515 +2.4%
Value US$273,408
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 79,360 +3.1%
Value US$141,261
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 49,640 +1.0%
Value US$88,359
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.65
Quantity 177,940 +7.4%
Value US$293,512
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.65
Quantity 80,421 +1.7%
Value US$132,654
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 35,703 +1.5%
Value US$63,651
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 122,641 +2.7%
Value US$218,644
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.71
Quantity 179,743 +4.1%
Value US$307,307
SPIEGELMAN DANIEL K Non-Executive Director
Transaction date
Sale
Price
1.72
Quantity 3,403 -14.2%
Value US$5,854
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.83
Quantity 41,526 +1.8%
Value US$76,009
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.83
Quantity 74,726 +1.7%
Value US$136,778
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 27,384 +1.2%
Value US$48,768
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.78
Quantity 55,531 +1.3%
Value US$98,895
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 5,000 +0.2%
Value US$8,750
BVF PARTNERS L P/IL See Explanation of Responses Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 10,300 +0.2%
Value US$18,025
SPIEGELMAN DANIEL K Non-Executive Director
Transaction date
Sale
Price
1.96
Quantity 12,780 -34.7%
Value US$25,054
Ayer Capital Management, LP Large shareholder
Transaction date
Sale
Price
8.74
Quantity 28,900 -1.0%
Value US$252,586
Karan Shashi K. Corporate Controller Officer
Transaction date
Purchase
Price
3.41
Quantity 5,100 +102.0%
Value US$17,411
Karan Shashi K. Corporate Controller Officer
Transaction date
Purchase
Price
5.08
Quantity 3,700 +284.6%
Value US$18,796
Karan Shashi K. Corporate Controller Officer
Transaction date
Purchase
Price
5.07
Quantity 100 +8.3%
Value US$507
Karan Shashi K. Corporate Controller Officer
Transaction date
Purchase
Price
5.05
Quantity 1,200 +inf%
Value US$6,060
Jackson Richard L. Non-Executive Director
Transaction date
Purchase
Price
2.60
Quantity 5,000 +inf%
Value US$13,000
Taylor Edward A. CFO, VP Fin Admin, Sec Officer
Transaction date
Purchase
Price
1.81
Quantity 4,450 +67.8%
Value US$8,054
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-08-14 2017-08-11 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
90,433 -21.3%
493.32
US$787,834 		90,433 -21.3% 493.32 US$787,834
2017-05-16 2017-05-12 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
86,308 -33.1%
244.64
US$2,385,324 		86,308 -33.1% 244.64 US$2,385,324
2017-04-04 2017-03-31 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
52,874 -37.1%
163.82
US$4,597,688 		52,874 -37.1% 163.82 US$4,597,688
2017-03-30 2017-03-28 B Purchase Fyfe Gwen A.
1,666 +100.0%
4.12
US$6,857 		1,666 +100.0% 4.12 US$6,857
2017-03-21 2017-03-20 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
1,000 +2.6%
3.93
US$3,927 		1,000 +2.6% 3.93 US$3,927
2017-02-03 2017-02-02 B Purchase LOVE TED W Non-Executive Director
23,000 +546.4%
4.24
US$97,520 		23,000 +546.4% 4.24 US$97,520
2017-02-01 2017-01-30 B Purchase HENNEY CHRISTOPHER S Non-Executive Director
25,324 +102.6%
4.11
US$103,973 		25,324 +102.6% 4.11 US$103,973
2017-01-31 2017-01-27 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
20,500 +114.4%
3.76
US$77,039 		20,500 +114.4% 3.76 US$77,039
2016-08-18 2016-08-17 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
45,000 +72.0%
1.15
US$51,746 		45,000 +72.0% 1.15 US$51,746
2016-06-28 2016-06-28 B Purchase Myers Scott Dunseth

President and CEO

Executive Director
62,500 +inf%
0.80
US$50,000 		62,500 +inf% 0.80 US$50,000
2015-06-03 2015-06-01 B Purchase HAUSMAN DIANA

Chief Medical Officer

Officer
5,747 +inf%
4.65
US$26,724 		5,747 +inf% 4.65 US$26,724
2015-04-01 2015-03-26 B Purchase SPIEGELMAN DANIEL K Non-Executive Director
10,000 +32.6%
1.59
US$15,856 		10,000 +32.6% 1.59 US$15,856
2015-04-01 2015-03-25 B Purchase SPIEGELMAN DANIEL K Non-Executive Director
10,000 +48.4%
1.63
US$16,271 		10,000 +48.4% 1.63 US$16,271
2014-12-17 2014-12-17 B Purchase BVF PARTNERS L P/IL Large shareholder
55,197 +1.7%
1.73
US$95,662 		55,197 +1.7% 1.73 US$95,662
2014-12-17 2014-12-17 B Purchase BVF PARTNERS L P/IL Large shareholder
98,298 +1.6%
1.73
US$170,360 		98,298 +1.6% 1.73 US$170,360
2014-12-17 2014-12-15 B Purchase BVF PARTNERS L P/IL Large shareholder
79,434 +2.5%
1.88
US$149,249 		79,434 +2.5% 1.88 US$149,249
2014-12-17 2014-12-15 B Purchase BVF PARTNERS L P/IL Large shareholder
145,515 +2.4%
1.88
US$273,408 		145,515 +2.4% 1.88 US$273,408
2013-11-05 2013-11-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
79,360 +3.1%
1.78
US$141,261 		79,360 +3.1% 1.78 US$141,261
2013-11-05 2013-11-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
49,640 +1.0%
1.78
US$88,359 		49,640 +1.0% 1.78 US$88,359
2013-08-12 2013-08-08 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
177,940 +7.4%
1.65
US$293,512 		177,940 +7.4% 1.65 US$293,512
2013-08-12 2013-08-08 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
80,421 +1.7%
1.65
US$132,654 		80,421 +1.7% 1.65 US$132,654
2013-08-02 2013-08-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
35,703 +1.5%
1.78
US$63,651 		35,703 +1.5% 1.78 US$63,651
2013-08-02 2013-08-01 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
122,641 +2.7%
1.78
US$218,644 		122,641 +2.7% 1.78 US$218,644
2013-08-02 2013-07-31 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
179,743 +4.1%
1.71
US$307,307 		179,743 +4.1% 1.71 US$307,307
2014-10-08 2013-07-10 S Sale SPIEGELMAN DANIEL K Non-Executive Director
3,403 -14.2%
1.72
US$5,854 		3,403 -14.2% 1.72 US$5,854
2013-06-07 2013-06-07 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
41,526 +1.8%
1.83
US$76,009 		41,526 +1.8% 1.83 US$76,009
2013-06-07 2013-06-07 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
74,726 +1.7%
1.83
US$136,778 		74,726 +1.7% 1.83 US$136,778
2013-06-07 2013-06-06 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
27,384 +1.2%
1.78
US$48,768 		27,384 +1.2% 1.78 US$48,768
2013-06-07 2013-06-06 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
55,531 +1.3%
1.78
US$98,895 		55,531 +1.3% 1.78 US$98,895
2013-06-07 2013-06-05 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
5,000 +0.2%
1.75
US$8,750 		5,000 +0.2% 1.75 US$8,750
2013-06-07 2013-06-05 B Purchase BVF PARTNERS L P/IL

See Explanation of Responses

Large shareholder
10,300 +0.2%
1.75
US$18,025 		10,300 +0.2% 1.75 US$18,025
2014-10-08 2013-02-20 S Sale SPIEGELMAN DANIEL K Non-Executive Director
12,780 -34.7%
1.96
US$25,054 		12,780 -34.7% 1.96 US$25,054
2011-06-27 2011-06-23 S Sale Ayer Capital Management, LP Large shareholder
28,900 -1.0%
8.74
US$252,586 		28,900 -1.0% 8.74 US$252,586
2010-09-29 2010-09-28 B Purchase Karan Shashi K.

Corporate Controller

Officer
5,100 +102.0%
3.41
US$17,411 		5,100 +102.0% 3.41 US$17,411
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
3,700 +284.6%
5.08
US$18,796 		3,700 +284.6% 5.08 US$18,796
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
100 +8.3%
5.07
US$507 		100 +8.3% 5.07 US$507
2009-08-18 2009-08-18 B Purchase Karan Shashi K.

Corporate Controller

Officer
1,200 +inf%
5.05
US$6,060 		1,200 +inf% 5.05 US$6,060
2008-02-14 2008-02-12 B Purchase Jackson Richard L. Non-Executive Director
5,000 +inf%
2.60
US$13,000 		5,000 +inf% 2.60 US$13,000
2008-01-18 2008-01-18 B Purchase Taylor Edward A.

CFO, VP Fin Admin, Sec

Officer
4,450 +67.8%
1.81
US$8,054 		4,450 +67.8% 1.81 US$8,054
Explore more

More insider trading research around Cascadian Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America